Photoaffinity labeling of P-glycoprotein in multidrug-resistant cells.

作者信息

Safa A R

机构信息

Department of Medicine, University of Chicago, Illinois 60637.

出版信息

Cancer Invest. 1993;11(1):46-56. doi: 10.3109/07357909309020260.

DOI:10.3109/07357909309020260

PMID:8093677

Abstract

摘要

相似文献

Photoaffinity labeling of P-glycoprotein in multidrug-resistant cells.

Cancer Invest. 1993;11(1):46-56. doi: 10.3109/07357909309020260.

Analysis of structural features of dihydropyridine analogs needed to reverse multidrug resistance and to inhibit photoaffinity labeling of P-glycoprotein.

Biochem Pharmacol. 1989 Feb 1;38(3):519-27. doi: 10.1016/0006-2952(89)90393-6.

Azidopine photoaffinity labeling of multidrug resistance-associated glycoproteins.

Biochem Pharmacol. 1988 Apr 1;37(7):1417-21. doi: 10.1016/0006-2952(88)90803-9.

P-glycoprotein transports corticosterone and is photoaffinity-labeled by the steroid.

Int J Cancer. 1992 Aug 19;52(1):141-6. doi: 10.1002/ijc.2910520125.

Multidrug resistance and its circumvention.

Eur J Cancer. 1990 Apr;26(4):513-5. doi: 10.1016/0277-5379(90)90028-r.

Multidrug resistance in human cancer.

Crit Rev Oncol Hematol. 1992;12(3):243-53. doi: 10.1016/1040-8428(92)90057-w.

Liposome-mediated modulation of multidrug resistance in human HL-60 leukemia cells.

J Natl Cancer Inst. 1992 Dec 16;84(24):1909-15. doi: 10.1093/jnci/84.24.1909.

The alpha 1-adrenergic photoaffinity probe [125I]arylazidoprazosin binds to a specific peptide of P-glycoprotein in multidrug-resistant cells.

Biochem Biophys Res Commun. 1990 Jan 15;166(1):259-66. doi: 10.1016/0006-291x(90)91939-p.

ATP-binding properties of P glycoprotein from multidrug-resistant KB cells.

FASEB J. 1987 Jul;1(1):51-4. doi: 10.1096/fasebj.1.1.2886389.

Mechanism of multidrug resistance.

Biochim Biophys Acta. 1988 Aug 3;948(1):87-128. doi: 10.1016/0304-419x(88)90006-6.

引用本文的文献

Providing a molecular mechanism for P-glycoprotein; why would I bother?

Biochem Soc Trans. 2015 Oct;43(5):995-1002. doi: 10.1042/BST20150131.

Development of novel rifampicin-derived P-glycoprotein activators/inducers. synthesis, in silico analysis and application in the RBE4 cell model, using paraquat as substrate.

PLoS One. 2013 Aug 26;8(8):e74425. doi: 10.1371/journal.pone.0074425. eCollection 2013.

Molecular analysis of the multidrug transporter, P-glycoprotein.

Cytotechnology. 1998 Sep;27(1-3):31-60. doi: 10.1023/A:1008023629269.

1-[4-(2-Aminoethoxy)phenylcarbonyl]-3,5-bis-(benzylidene)-4-oxopiperidines: a novel series of highly potent revertants of P-glycoprotein associated multidrug resistance.

Bioorg Med Chem Lett. 2008 Jun 15;18(12):3484-7. doi: 10.1016/j.bmcl.2008.05.034. Epub 2008 May 16.

Identification and characterization of the binding sites of P-glycoprotein for multidrug resistance-related drugs and modulators.

Curr Med Chem Anticancer Agents. 2004 Jan;4(1):1-17. doi: 10.2174/1568011043482142.

Detection of recombinant P-glycoprotein in multidrug resistant cultured cells.

Mol Biotechnol. 2000 Feb;14(2):131-45. doi: 10.1385/MB:14:2:131.

Different effects of FK317 on multidrug-resistant tumor in vivo and in vitro.

Jpn J Cancer Res. 1998 Oct;89(10):1047-54. doi: 10.1111/j.1349-7006.1998.tb00495.x.

Inhibition of protein kinase C in multidrug-resistant cells by modulators of multidrug resistance.

J Cancer Res Clin Oncol. 1997;123(4):201-10. doi: 10.1007/BF01240316.

Differential effectiveness of a range of novel drug-resistance modulators, relative to verapamil, in influencing vinblastine or teniposide cytotoxicity in human lymphoblastoid CCRF-CEM sublines expressing classic or atypical multidrug resistance.

Cancer Chemother Pharmacol. 1994;33(4):317-24. doi: 10.1007/BF00685907.

Molecular analysis of the multidrug transporter.

Cytotechnology. 1993;12(1-3):33-62. doi: 10.1007/BF00744657.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验